These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 32468741)

  • 41. Comparative bioavailability and pharmacokinetics of investigational enteric- and film-coated formulations of flurbiprofen 100-mg tablets: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Pakistani male volunteers.
    Ahmad M; Pervaiz F
    Clin Ther; 2010 Mar; 32(3):607-13. PubMed ID: 20399997
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetic and bioequivalence study of etoricoxib tablet in healthy Bangladeshi volunteers.
    Shohag MH; Islam MS; Ahmed MU; Joti JJ; Islam MS; Hasanuzzaman M; Hasnat A
    Arzneimittelforschung; 2011; 61(11):617-21. PubMed ID: 22232850
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bioequivalence of two levothyroxine tablet formulations without and with mathematical adjustment for basal thyroxine levels in healthy Argentinian volunteers: a single-dose, randomized, open-label, crossover study.
    Di Girolamo G; Keller GA; de Los Santos AR; Schere D; Gonzalez CD
    Clin Ther; 2008 Nov; 30(11):2015-23. PubMed ID: 19108789
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A randomized, open-label, two-period, crossover bioavailability study of two oral formulations of tacrolimus in healthy Korean adults.
    Park K; Kim YS; Kwon KI; Park MS; Lee YJ; Kim KH
    Clin Ther; 2007 Jan; 29(1):154-62. PubMed ID: 17379055
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetic comparison of two bazedoxifene acetate 20 mg tablet formulations in healthy Korean male volunteers.
    Yeun JS; Kan HS; Lee M; Kim N; Oh TY; Nam SK; Choi YS; Kwon IS; Hong JH
    Transl Clin Pharmacol; 2020 Jun; 28(2):102-108. PubMed ID: 32656161
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Results of a single-center, single-dose, randomized-sequence, open-label, two-way crossover bioequivalence study of two formulations of valsartan 160-mg tablets in healthy volunteers under fasting conditions.
    Spínola AC; Almeida S; Filipe A; Neves R; Trabelsi F; Farré A
    Clin Ther; 2009 Sep; 31(9):1992-2001. PubMed ID: 19843489
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bioavailability of two single-dose oral formulations of omeprazole 20 mg: an open-label, randomized sequence, two-period crossover comparison in healthy Mexican adult volunteers.
    Poo JL; Galán JF; Rosete A; de Lago A; Oliva I; González-de la Parra M; Jiménez P; Burke-Fraga V; Namur S
    Clin Ther; 2008 Apr; 30(4):693-9. PubMed ID: 18498918
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics and relative bioavailability of fixed-dose combination of clopidogrel and aspirin versus coadministration of individual formulations in healthy Korean men.
    Choi HK; Ghim JL; Shon J; Choi YK; Jung JA
    Drug Des Devel Ther; 2016; 10():3493-3499. PubMed ID: 27822013
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bioequivalence of two film-coated tablets of imatinib mesylate 400 mg: a randomized, open-label, single-dose, fasting, two-period, two-sequence crossover comparison in healthy male South American volunteers.
    Parrillo-Campiglia S; Ercoli MC; Umpierrez O; Rodríguez P; Márquez S; Guarneri C; Estevez-Parrillo FT; Laurenz M; Estevez-Carrizo FE
    Clin Ther; 2009 Oct; 31(10):2224-32. PubMed ID: 19922893
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of pharmacokinetic characteristics of two Tegoprazan (CJ-12420) formulations in healthy male subjects.
    Hwang JG; Yoo H; Lee JW; Song GS; Lee S; Kim MG
    Transl Clin Pharmacol; 2019 Jun; 27(2):80-85. PubMed ID: 32055586
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative pharmacokinetics of two formulations of 2.5-mg rivaroxaban in healthy Korean subjects.
    Moon SJ; Kim Y; Kim SY; Jeon JY; Song E; Lim Y; Kim MG
    Int J Clin Pharmacol Ther; 2023 Mar; ():. PubMed ID: 36871246
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mycophenolate mofetil 500-mg tablet under fasting conditions: single-dose, randomized-sequence, open-label, four-way replicate crossover, bioequivalence study in healthy subjects.
    Almeida S; Filipe A; Neves R; Spínola AC; Tanguay M; Ortuño J; Farré A; Torns A
    Clin Ther; 2010 Mar; 32(3):556-74. PubMed ID: 20399993
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetic equivalence study of two formulations of the anticonvulsant pregabalin.
    Tjandrawinata RR; Setiawati E; Putri RS; Gunawan VA; Ong F; Susanto LW; Nofiarny D
    Clin Pharmacol; 2015; 7():69-75. PubMed ID: 25945069
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetic and safety profile of rupatadine when coadministered with azithromycin at steady-state levels: a randomized, open-label, two-way, crossover, Phase I study.
    Solans A; Izquierdo I; Donado E; Antonijoan R; Peña J; Nadal T; Carbó ML; Merlos M; Barbanoj M
    Clin Ther; 2008 Sep; 30(9):1639-50. PubMed ID: 18840369
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetic comparison of a new sustained-release formulation of glimepiride/metformin 1/500 mg combination tablet and a sustained-release formulation of glimepiride/metformin 2/500 mg combination tablet in healthy Korean male volunteers: a randomized, 2-sequence, 2-period, 2-treatment crossover study.
    Shin KH; Kim SE; Yoon SH; Cho JY; Jang IJ; Shin SG; Yu KS
    Clin Ther; 2011 Nov; 33(11):1809-18. PubMed ID: 22036245
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relative bioavailability and pharmacokinetic properties of two different enteric formulations of esomeprazole in healthy Bangladeshi male volunteers: An open-label, single-dose, randomized-sequence, two-way crossover study.
    Ullah MA; Shams-Ud-Dowla ; Maruf AA; Azad MA; Shohag MH; Sultana R; Latif AH; Hasnat A
    Clin Ther; 2010 Jul; 32(7):1419-26. PubMed ID: 20678688
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A randomized, single-dose, two-sequence, two-period, crossover study to assess the bioequivalence between two formulations of clonazepam tablet in healthy subjects.
    Davanço MG; Meulman J; Guzmán MRP; Palomino DMH; Tuiran CMG; Duarte FG; de Campos DR
    Drug Dev Ind Pharm; 2019 Dec; 45(12):1982-1987. PubMed ID: 31702402
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A randomised, two-period, cross-over, open-label study to evaluate the pharmacokinetic profiles of single doses of two different flurbiprofen 8.75-mg lozenges in healthy volunteers.
    Matzneller P; Burian A; Martin W; Annoni O; Lauro V; Tacchi R; Brunner M; Zeitlinger M
    Pharmacology; 2012; 89(3-4):188-91. PubMed ID: 22433300
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bioequivalence of a New Oral Levosulpiride Formulation Compared With a Standard One in Healthy Volunteers.
    De Gregori S; Cipollina L; De Silvestri A; Ventura M; Michelini R; Morosini M; Montagna M; Tinelli C; Regazzi M; Molinaro M; Imberti R
    Ther Drug Monit; 2017 Apr; 39(2):118-123. PubMed ID: 28196046
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetic and bioavailability studies of 5 mg mosapride tablets in healthy Korean volunteers.
    Kim SH; Park YS; Kim JM; Park HJ; Lee MH; Park HK; Kim YJ; Cho SH; Shaw LM; Kang JS
    Int J Clin Pharmacol Ther; 2012 Jul; 50(7):524-31. PubMed ID: 22541755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.